Lymphocyte and monocyte subset changes during cardiopulmonary bypass: Effects of aging and gender

Journal of Laboratory and Clinical Medicine

Volumn 129, Issue 6, 1997, Pages 592-602

  Rinder, Christine S ^a   Mathew, Joseph P ^a   Rinder, Henry M ^a   Tracey, Jayne B ^a   Davis, Elizabeth ^a   Smith, Brian R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031171474     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(97)90193-1     Document Type: Article

References (45)

1. Englelman RM, Chase RM, Boyd A, Reed GE. Lethal post-operative infections following cardiac surgery. Circulation 1973;67(suppl 3):31-6.
2. Wells FC, Newsom SWB, Rowlands C. Wound infection in cardiothoracic surgery. Lancet 1983;1:1209-10.
3. Sarr MG, Gott VL, Townsend TR. Mediastinal infection after cardiac surgery. Ann Thorac Surg 1984;38:415-23.
4. Sakakibara T, Juji T. Post-transfusion graft-versus-host disease after open heart surgery. Lancet 1986;2:1099.
5. Sakakibara T, Ida T, Mannouji E, Kikuchi T, Tatsuno K, Kawase M, et al. Post-transfusion graft-versus-host disease following open heart surgery: A report of 6 cases. J Cardiovasc Surg (Torino) 1989;30:687-91.
6. Brody J, Pickering N, Fink G, Behr E. Altered lymphocyte subsets during cardiopulmonary bypass. Am J Clin Pathol 1987;87:626-8.
7. Roth J, Golub S, Cukingnan R, et al. Cell-mediated immunity is depressed following cardiopulmonary bypass. Ann Thorac Surg 1981;31:351-6.
8. Velzen-Blad H van, Dijkstra YJ, Heijnen C, et al. Cardiopulmonary bypass and host defense functions in human beings: II. Lymphocyte function. Ann Thorac Surg 1985; 39:212-7.
9. Ryhanen P, Ilonen J, Surcel HM, et al. Characterization of in vivo activated lymphocytes found in the peripheral blood of patients undergoing cardiac operation. J Thorac Cardiovasc Surg 1987;93:109-14.
10. Ide H, Kakiuchi T, Furuta N, et al. The effect of cardiopulmonary bypass on T cells and their subpopulations. Ann Thorac Surg 1987;44:277-82.
11. Rinder C, Bonan J, Rinder H, et al. Cardiopulmonary bypass induces leukocyte-platelet adhesion. Blood 1992;79:1201-5.
12. He G-W, Acuff T, Ryan W, et al. Determinants of operative mortality in elderly patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 1994;108:73-81.
13. Lesourd BM, Meaume S. Cell mediated immunity changes in aging: Relative importance of cell subpopulation switches and of nutritional factors. Immunol Lett 1994;40:235-42.
14. Fernandez J, Laub GW, Adkins MS, et al. Early and latephase events after valve replacement with the St. Jude Medical prosthesis in 1200 patients. J Thorac Cardiovasc Surg 1994;107:394-406.
15. Lawrence J. T-cell subsets in health, infectious disease, and idiopathic CD4+ T lymphocytopenia. Ann Intern Med 1993; 119:55-62.
16. Perttila J, Salo M, Pirttikangas C-O, et al. Effects of cardiopulmonary bypass on lymphocytes and their subset counts with or without use of autotransfusion devices. J Cardiothorac Vase Anesth 1994;8:532-35.
17. Utley JR. Renal function and fluid balance with cardiopulmonary bypass. In: Gravlee GP, Davis RF, Utley JR, editors. Cardiopulmonary bypass: Principles and practice. Baltimore: Williams & Wilkins, 1993:469-99.
18. van Kooyk Y, Figdor CG. Activation and inactivation of adhesion molecules. Curr Top Microbiol Immunol 1993;184:235-45.
19. Luscinskas FW, Ding H, Lichtman AH. P-selectin and vascular cell adhesion molecule 1 mediate rolling and arrest, respectively, of CD4+ T lymphocytes on tumor necrosis factor α-activated vascular endothelium under flow. J Exp Med 1995;181:1179-86.
20. Hershman MJ, Cheadle WG, Wellhausen ST, et al. Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patient. Br J Surg 1990;77:204-7.
21. Lin R, Astiz M, Saxon J, Rackow E. Altered leukocyte immunophenotypes in septic shock. Chest 1993;104:847-53.
22. Knon K, Sekikawa T, Matsumoto Y. Influence of surgical stress on monocytes and complications of infection in patients with esophageal cancer: Monocyte HLADr antigen expression and respiratory burst capacity. J Surg Res 1995; 58:275-80.
23. Cheadle WG. The human leukocyte antigens and their relationship to infection. Am J Surg 1993;165(suppl 2A):78S-81S.
24. Wakefeld CH, Carey PD, Foulds S, Monson JR, Guillou PJ. Changes in major histocompatibility complex class II expression in monocytes and T cells of patients developing infection after surgery. Br J Surg 1993;80:205-9.
25. Polk HC Jr, George CD, Wellhausen SR, Cost K, Davidson PR, Regan MP, et al. A systematic study of host defense processes in badly injured patients. Ann Surg 1986;204:282-99.
26. Clarkson SB, Ory PA. Developmentally regulated IgG Fc receptors on cultured human monocytes. J Exp Med 1988; 167:408.
27. Smith BR, Ault KA. Increase of surface Ia-like antigen expression on human monocytes independent of antigenic stimuli. J Immunol 1981;127:2020-7.
28. Foti M, Lew DP, Carpentier JL, Krause KH. CD4 in non-lymphocytic cells: More than an HIV receptor? J Lab Clin Med 1995;1126:233-9.
29. Faltynek CR, Finch LR, Miller P, Overton WR. Treatment with recombinant IFN-gamma decreases cell surface CD4 levels on peripheral blood monocytes and on myelomonocyte cell lines. J Immunol 1989;142:500-8.
30. Butler J, Rocker GM, Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1993;55:552-9.
31. Fosse E, Opdahl H, Aakvaag A, Svennevig JL, Sunde S. White blood cell populations in patients undergoing major vascular surgery. Scand J Thorac Cardiovasc Surg 1985;19: 247-52.
32. DePalma L, Yu MT, McIntosh CL, Swain JA, Daveu RJ. Changes in lymphocyte subpopulations as a result of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1991;101:240-4.
33. Hisatomi K, Isomura T, Kawara T, et al. Changes in lymphocyte subsets, mitogen responsiveness, and interleukin-2 production after cardiac operations. J Thorac Cardiovasc Surg 1989;98:581-91.
34. Lotzová E. Definition and functions of natural killer cells. Nat Immun 1992;12:169-76.
35. Aso T, Asano Y, Harada M, et al. Transfusion-associated graft-versus-host disease following transfusion during open heart surgery. Acta Hematol Jpn 1989;52:1064-71.
36. Anderson KC, Weinstein HJ. Transfusion-associated graft-versus-host disease. N Engl J Med 1990;323:315-21.
37. Linden JV, Pisciotto PT. Transfusion-associated graft-versus-host disease and blood irradiation. Transfus Med Rev 1992; 7:116-23.
38. Otsuka S, Kunieda K, Hirose M, et al. Fatal erythroderma (suspected graft-versus-host disease) after cholecystectomy: Retrospective analysis. Transfusion 1989;29:544-8.
39. Ino T, Matsuura A, Takahashi R, et al. GVHD-like syndrome following transfusion at the time of surgery. Geka 1986;48:706-12.
40. Thaler M, Shamiss A, Orgad S, et al. The role of blood from HLA-homozygous donors in fatal transfusion-associated graft-versus-host disease after open heart surgery. N Engl J Med 1989;32:25-7.
41. Arsura EL, Bertelle A, Minkowitz S, et al. Transfusion-associated graft-vs-host disease in a presumed immunocom-3 petent patient. Arch Intern Med 1988;148;1941-8.
42. Grmoljez PF, Barner HH, Willman VL, Kaiser GC. Major complications of median sternotomy. Am J Surg 1975;130: 679-84.
43. Culliford AT, Cunningham JN, Zeff RH, et al. Sternal and costrocondral infections following open-heart surgery: A review of 2,594 cases. J Thorac Cardiovasc Surg 1976;72:714.
44. Wallace RJ, Musser JM, Hill SI, et al. Diversity and sources of rapidly growing mycobacteria associated with infections following cardiac surgery. J Infect Dis 1989;159:708-16.
45. Rinder CS, Gaal D, Student LA, Smith BR. Platelet-leukocyte activation and modulation of adhesion receptors in pé diatric congenital heart disease patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1994;107:280-8.